CHIDOCHOMOYO ZVIRAWA: Open Payments
NPI 1790344968 · TROY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 55 payments from 11 companies in 2025. Trend: 2023 $1,666 · 2024 $1,156 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $226 |
| ABBVIE INC. | 10 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $142 |
| Janssen Pharmaceuticals, Inc | 8 | $140 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Axsome Therapeutics, Inc. | 2 | $89 |
| Alkermes, Inc. | 4 | $87 |
| Lundbeck LLC | 3 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
Products named: COBENFY, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, REXULTI, Auvelity, ARISTADA, Jornay PM.
Industry payments across MO — which companies pay providers there.
